News stories

A member of the Centre for Liver and Gastrointestinal Research (CLGR) data team has recently stepped onto the international stage to present original research at a major conference dedicated to neuroendocrine tumours (NETs). 

Jaya Sharma, Data Manager for the CLGR, was among a delegation of UHB staff who attended the 22nd annual European Neuroendocrine Tumour Society (ENETS) conference in Krakow, Poland, earlier this year. 

The ENETS, founded in 2004, is the longest-established society dedicated to improving the diagnosis and treatment of NETS, through raising awareness and advancing research.  

In her role as database manager, Jaya is responsible for maintaining and analysing the dataset for neuroendocrine tumour and hepatocellular carcinoma patients at the CLGR.  

In the last ten months since starting her role, Jaya has also worked the wider neuroendocrine tumour team, led by Dr Tahir Shah, in profiling patients with carcinoid heart disease. Their research findings revealed that diagnoses are often delayed due to late symptom onset and the presence of untreated carcinoid syndrome. 

Jaya concluded that earlier detection, screening and diagnosis, along with enhanced MDT management, could potentially improve patient prognoses and outcomes. Jaya's findings were discussed with the team and compiled into a formal clinical poster, which was submitted to the ENETS conference and accepted for presentation. 

Daniel Kearns, Head Biomedical Scientist and Laboratory Manager for the CLGR, said: “The Liver Unit and CLGR are extremely proud to have a member of our data team representing the Trust and showcasing the benefits of collaborative working at the international conference.  

“Jaya’s success highlights her hard work and dedication, showing that all staff, whether directly or indirectly involved in patient care, can contribute valuable insights into clinical practice. We encourage all UHB staff, regardless of role, to explore research opportunities in areas that interest them - it’s a rewarding experience that can make a meaningful impact.” 

After presenting at the conference, Jaya said: “The conference not only highlighted the progress being made but also emphasised the collaborative spirit driving the growth of the NET field. 

“It was incredibly rewarding to see the passion and commitment of professionals working tirelessly to ensure better outcomes for those affected by neuroendocrine tumours. Krakow proved to be the perfect backdrop for this enlightening experience, leaving me motivated and more determined than ever to contribute to meaningful change in this area”. 

Jaya’s work will be compiled into a formal scientific paper and submitted to a relevant NET-related journal for consideration.